First collaborative study: EU2Control
EU2Control: The first collaborative study
We're launching an international study in 11 European countries to learn more about people who can control HIV after having stopped treatment. Post-treatment controllers are rare (4-7%), and we need more of them in our research to understand how they do it. By learning how the body controls the virus, we believe we can develop HIV cure strategies. Our aim is to build the largest cohort of post-treatment controllers globally. The first phase of the study is funded by Gilead and the study was officially launched during the EU2Cure workshop and meeting at Aarhus, Denmark.